Bladder Neck Morphologic Changes and Clinical Correlation of Smokers Submitted to Radical Prostatectomy

L. C. N. Araujo, W. S. Costa, F. O. Vilar, S. V. C. Lima, F. J. B. Sampaio

Urogenital Research Unit, State University of Rio de Janeiro, RJ, Brazil.
Urology Department, Hospital das Clinicas, Federal University of Pernambuco, PE, Brazil.

DOI: 10.4236/oju.2013.36043                

Abstract

Introduction: Smoking is an important risky factor to many diseases, affecting arterial system, skin and urogenital system, including bladder neck stenosis. Its effect on bladder neck has not been described. Objective: Evaluate possible morphological changes caused by nicotine in the bladder neck. Material and Method: Fragments of bladder neck of 16 patients were submitted to stereological analysis, and those patients are divided into two groups, one of smokers and the other of non-smokers with 7 and 9 patients, respectively. After 90 days of surgery, they were submitted to free uroflowmetry and data analyzed by T test, having statistical significance with P < 0.05. Results: An increase of 63.26% in the amount of fibers in the elastic system of the smokers group was observed, a reduction of 35.96% in the thickness of arteries, as well as an increase of IPSS and decrease of maximum flow in uroflowmetry, all with statistical significance. Discussion: Laboratorial changes are similar to those found in other studies with different tissues, such as skin, in which those findings are related to premature ageing. Clinical results, though statistically significant, do not have clinical consistence because the study was meant to morphological analysis. Conclusion: Smoking increases the amount of fibers in the elastic system and decreases the thickness of bladder neck arteries.

Keywords

Smoking; Bladder Neck; Elastic Fibers; Uroflowmetry

Conflicts of Interest

The authors declare no conflicts of interest.

References

[1]	S. T. Hanna, “Nicotine Effect on Cardiovascular System and Ion Channels,” Journal of Cardiovascular Pharmacology, Vol. 47, No. 3, 2006, pp. 348-358.
[2]	U. John, S. E. Baumeister, C. Kessler and H. Volzke, “Associations of Carotid Intima-Media Thickness, Tobacco Smoking and Overweight with Hearing Disorder in a General Population Sample,” Atherosclerosis, Vol. 195, No. 1, 2007, pp. e144-e149. http://dx.doi.org/10.1016/j.atherosclerosis. 2007.04.007
[3]	N. Lindenblatt, U. Platz, J. Hameister, E. Klar, M.D. Menger and B. Vollmar, “Distinct Effects of Acute and Chronic Nicotine Application on Microvascular Thrombus Formation and Endothelial Function in Male and Female Mice,” Langenbeck’s Archives of Surgery, Vol. 392, No. 3, 2007, pp. 285-295. http://dx.doi.org/10.1007/s00423-007-0173-6
[4]	W. J. Mack, T. Islam, Z. R. H. Lee, Selzer, et al., “Environmental Tobacco Smoke and Carotid Arterial Stiffness,” Preventive Medicine, Vol. 37, No. 2, 2003, pp. 148-154. http://dx.doi.org/10.1016/S0091-7435(03)00097-5
[5]	M. Just, Ribera, M. Monso, E. Lorenzo, J. C. Lorenzo and C. Ferrándiz, “Effect of Smoking on Skin Elastic Fibres: Morphometric and Immunohistochemical Analysis,” British Journal of Dermatology, Vol. 156, No. 1, 2007, pp. 85-91. http://dx.doi.org/10.1111/j.1365-2133.2006.07575.x
[6]	A. Morita, “Tobacco Smoke Causes Premature Skin Aging,” Journal of Dermatological Science, Vol. 48, No. 3, 2007, pp. 169-175. http://dx.doi.org/10.1016/j.jdermsci.2007.06.015
[7]	H. Tanaka, Y. Ono, Y. Nakata, N. Shintani, et al., “Tobacco Smoke Extract Induces Premature Skin Aging in Mouse,” Journal of Dermatological Science, Vol. 46, No. 1, 2007, pp. 69-71. http://dx.doi.org/10.1016/j.jdermsci. 2006.11.009
[8]	G. D. Batty, M. Kivimaki, G. D. Gray, M. G. Smith, et al., “Cigarette Smoking and Site-Specific Cancer Mortality: Testing Uncertain Associations Using Extended Follow-up of the Original Whitehall Study,” Annals of Oncology, Vol. 191, No. 5, 2008, pp. 996-1002.
[9]	S. Boorjian, J. E. Cowan, B. R. Konety, J. DuChane, et al., “Bladder Cancer Incidence and Risk Factors in Men with Prostate Cancer: Results from Cancer of the Prostate Strategic Urologic Research Endeavor,” Journal of Urology, Vol. 177, No. 3, 2007, pp. 883-887.
[10]	P. G. Borboroglu, J. P. Sands, J. L. Roberts and C. L. Amling, “Risk Factors for Vesicourethral Anastomotic Stricture after Radical Prostatectomy,” Urology, Vol. 56, No. 1, 2000, pp. 96-100. http://dx.doi.org/10.1016/S0090-4295(00)00556-2
[11]	K. Hickey, K.-A. Do and A. Green, “Smoking and Prostate Cancer,” Epidemiologic Reviews, Vol. 23, No. 1, 2001, pp. 115-125. http://dx.doi.org/10.1093/oxfordjournals.epirev.a000776
[12]	J. K. Parsons, “Modifiable Risk Factors for Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: New Approaches to Old Problems,” Journal of Urology, Vol. 178, No. 2, 2007, pp. 395-401. http://dx.doi.org/10.1016/j.juro.2007.03.103
[13]	J. Y. Polsky, K. J. Aronson, J. P. W. Heaton and M. A. Adams, “Smoking and Other Lifestyle Factors in Relation to Erectile Dysfunction,” BJU International, Vol. 96, No. 9, 2005, pp. 1355-1359. http://dx.doi.org/10.1111/j.1464-410X.2005.05820.x
[14]	F. Sommer and M. J. Mathers, “Lifestyle, Erectile Dysfunction, Hormones and Metabolic Syndrome. Opportunities for Gender-Specific Prevention for Men,” Urologe A, Vol. 46, No. 6, 2007, pp. 628-635.
[15]	N. Rodrigues Netto, M. L. de Lima, E. F. M. de Andrade, F. Apuzzo, et al., “Latin American Study on Patient Acceptance of the International Prostate Symptom Score (IPSS) in the Evaluation of Symptomatic Benign Prostatic Hyperplasia,” Urology, Vol. 49, No. 1, 1997, pp. 46-49. http://dx.doi.org/10.1016/S0090-4295(96)00372-X
[16]	J. Laitakari and F. Stenback, “Collagen Matrix in Development and Progression of Experimentally Induced Respiratory Neoplasms in the Hamster,” Journal of Toxicologic Pathology, Vol. 29, No. 5, 2001, pp. 514-527. http://dx.doi.org/10.1080/019262301317226311
[17]	M. M. Rahman and I. Laher, “Structural and Functional Alteration of Blood Vessels Caused by Cigarette Smoking: An Overview of Molecular Mechanisms,” Current Vascular Pharmacology, Vol. 5, No. 4, 2007, pp. 276-292. http://dx.doi.org/10.2174/157016107782023406
[18]	C.-W. Shen, Y.-H. Wang, Y.-C. Jou, et al., “Inducible Nitric Oxide Synthase Promoter Polymorphism, Cigarette Smoking, and Urothelial Carcinoma Risk,” Urology, Vol. 69, No. 5, 2007, pp. 1001-1006. http://dx.doi.org/10.1016/j.urology.2007.02.028
[19]	H. Yin, L. Chao and J. Chao, “Nitric Oxide Mediates Cardiac Protection of Tissue Kallikrein by Reducing Inflammation and Ventricular Remodeling after Myocardial Ischemia/Reperfusion,” Life Sciences, Vol. 82, No. 3-4, 2008, pp. 156-165. http://dx.doi.org/10.1016/j.lfs.2007.10.021
[20]	A. W. Y. Chung, H. H. C. Yang, J. M. Kim, M. K. Sigrist, et al., “Upregulation of Matrix Metalloproteinase-2 in the Arterial Vasculature Contributes to Stiffening and Vasomotor Dysfunction in Patients with Chronic Kidney Disease,” Circulation, Vol. 120, No. 9, 2009, pp. 792-801. http://dx.doi.org/10.1161/ CIRCULATIONAHA.109.862565
[21]	H. Gullu, M. Caliskan, O. Ciftci, D. Erdogan, et al., “Light Cigarette Smoking Impairs Coronary Microvascular Functions as Severely as Smoking Regular Cigarettes,” Heart, Vol. 93, No. 10, 2007, pp. 1274-1277. http://dx.doi.org/10.1136/hrt.2006.100255
[22]	M. Raveendran, D. Senthil, B. Utama, Y. Shen, et al., “Cigarette Suppresses the Expression of P4Halpha and Vascular Collagen Production,” Biochemical and Biophysical Research Communications, Vol. 323, No. 2, 2004, pp. 592-598. http://dx.doi.org/10.1016/j.bbrc.2004.08.129